Literature DB >> 33127651

Antithrombotic therapy for patients with chronic coronary syndromes.

William Ae Parker1,2, Robert F Storey3,2.   

Abstract

Entities:  

Keywords:  chronic coronary disease

Mesh：

Substances：

Year:  2020        PMID： 33127651     DOI： 10.1136/heartjnl-2020-316914

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  2 in total

Review 1.  Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium.

Authors:  Diana A Gorog; Robert F Storey; Paul A Gurbel; Udaya S Tantry; Jeffrey S Berger; Mark Y Chan; Daniel Duerschmied; Susan S Smyth; William A E Parker; Ramzi A Ajjan; Gemma Vilahur; Lina Badimon; Jurrien M Ten Berg; Hugo Ten Cate; Flora Peyvandi; Taia T Wang; Richard C Becker
Journal:  Nat Rev Cardiol       Date:  2022-01-13       Impact factor: 49.421

2.  A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control.

Authors:  Robert F Storey; Ramzi A Ajjan; William A E Parker; Rebecca Sagar; Zeyad Kurdee; Fladia Hawkins; Khalid M Naseem; Peter J Grant
Journal:  Cardiovasc Diabetol       Date:  2021-12-17       Impact factor: 8.949
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.